Product Details for: Phesgo

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
1,200MG, 600MG, 30,000UNITS/15ML (80MG, 40MG, 2,000UNITS/ML)
Single-Dose Vial
351(a)
Phesgo
Rx
002
Injection
Subcutaneous
600MG, 600MG, 20,000UNITS/10ML (60MG, 60MG, 2,000UNITS/ML)
Single-Dose Vial
351(a)
Phesgo
Rx
Proper Name
pertuzumab, trastuzumab, and hyaluronidase-zzxf
BLA Number
761170
Applicant
Genentech, Inc.
Original Approval Date
June 29, 2020
Date of First Licensure
RETURN TO SEARCH RESULTS